These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19267173)

  • 1. Cryptococcal cerebellitis after chemotherapy and autologous stem cell re-infusion in a patient with multiple myeloma.
    Fickweiler W; Aries MJ; Enting RH; Vellenga E; De Keyser J
    J Neurol; 2009 Jan; 256(1):145-6. PubMed ID: 19267173
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryptococcal meningitis following autologous stem cell transplantation in a patient with multiple myeloma.
    Mendpara SD; Ustun C; Kallab AM; Mazzella FM; Bilodeau PA; Jillella AP
    Bone Marrow Transplant; 2002 Aug; 30(4):259-60. PubMed ID: 12203144
    [No Abstract]   [Full Text] [Related]  

  • 3. Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in a Patient with Concomitant Porphyria Cutanea Tarda.
    Mohamed ZA; Pelletier S; Vintze-Geoffrion A; Lagacé-Nadon S; Olney HJ; Adam JP
    Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e264-e266. PubMed ID: 33390349
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy experience.
    Muzaffar J; Usmani S; Abdallah AO; Anaissie E; Cottler-Fox M; Restrepo A
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):171-4. PubMed ID: 23313066
    [No Abstract]   [Full Text] [Related]  

  • 5. Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant.
    Radujkovic A; Hundemer M; Eisenbach C; Luft T; Penzel R; Goldschmidt H; Ho AD; Bellos F
    Leuk Lymphoma; 2014 Dec; 55(12):2967-9. PubMed ID: 24707945
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous peripheral blood progenitor cell transplantation for multiple myeloma.
    Attal M; Harousseau JL
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):171-91. PubMed ID: 11000991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantation.
    Fleming S; Harrison SJ; Blombery P; Joyce T; Stokes K; Seymour JF; Prince HM; Ritchie D
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):291-6. PubMed ID: 24629850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous and allogeneic stem cell transplantation in multiple myeloma.
    Goldschmidt H; Egerer G; Ho AD
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S25-6. PubMed ID: 10933182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation in multiple myeloma.
    Topolsky D; Biggs D
    Semin Oncol; 1995 Jun; 22(3):230-7. PubMed ID: 7777867
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
    Veltri LW; Milton DR; Delgado R; Shah N; Patel K; Nieto Y; Kebriaei P; Popat UR; Parmar S; Oran B; Ciurea S; Hosing C; Lee HC; Manasanch E; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH; Bashir Q
    Cancer; 2017 Sep; 123(18):3568-3575. PubMed ID: 28513828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier.
    Kentos A; Vekemans M; Van Vooren JP; Lambermont M; Liesnard C; Feremans W; Farber CM
    Bone Marrow Transplant; 2002 Feb; 29(3):273-5. PubMed ID: 11859402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
    Tosi P; Zamagni E; Ronconi S; Benni M; Motta MR; Rizzi S; Tura S; Cavo M
    Leukemia; 2000 Jul; 14(7):1310-3. PubMed ID: 10914557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myeloma.
    Koh LP; Linn YC; Teoh G; Goh YT; Tan PH
    Ann Acad Med Singap; 2002 Nov; 31(6):731-7. PubMed ID: 12520826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of high dose chemotherapy and autologous stem cell transplantation in elderly patients with multiple myeloma: A single-center retrospective analysis.
    Wiebach H; Gezer D; Brummendorf TH; Crysandt M; Wilop S
    Curr Res Transl Med; 2020 Aug; 68(3):139-144. PubMed ID: 32381471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patients.
    Farag S; Jeker B; Bacher U; Mansouri Taleghani B; Mueller BU; Novak U; Pabst T
    Hematol Oncol; 2018 Oct; 36(4):671-678. PubMed ID: 30110717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation.
    Mürner CM; Stenner-Liewen F; Seifert B; Mueller NJ; Schmidt A; Renner C; Schanz U; Knuth A; Manz MG; Scharl M; Gerber B; Samaras P
    Leuk Lymphoma; 2019 Mar; 60(3):685-695. PubMed ID: 30126310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014.
    D'Souza A; Zhang MJ; Huang J; Fei M; Pasquini M; Hamadani M; Hari P
    Leukemia; 2017 Sep; 31(9):1998-2000. PubMed ID: 28663578
    [No Abstract]   [Full Text] [Related]  

  • 19. NCCN: Multiple myeloma.
    Traynor AE; Noga SJ;
    Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma.
    Joks M; Jurczyszyn A; Machaczka M; Skotnicki AB; Komarnicki M
    Eur J Haematol; 2015 Feb; 94(2):109-14. PubMed ID: 25039659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.